Purchases and Sales Made in Q3 2024 in Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX) during Q3 2024. The information is specifically focused on institutions that hold shares of Gain Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Joel Greenblatt
Gotham Asset Management, LLC | New York, Ny
|
BUY
|
- |
335KNew |
$315K - $666K
|
335K
$575K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
88.2K+ 48.02% |
$82.9K - $176K
|
272K
$468K
|
|
|
Nov 12, 2024
Q3 2024
|
Jones Financial Companies Lllp
|
BUY
|
- |
46.5K+ 664.29% |
$43.7K - $92.5K
|
53.5K
$92K
|
|
|
Nov 13, 2024
Q3 2024
|
Sandhill Capital Partners LLC
Buffalo, NY |
BUY
|
- |
15.4KNew |
$14.5K - $30.6K
|
15.4K
$26.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.11K+ 180.05% |
$2.93K - $6.19K
|
4.84K
$8.33K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.5K+ 45.45% |
$1.41K - $2.99K
|
4.8K
$8.26K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
84+ 2.4% |
$79 - $167
|
3.58K
$6.16K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-2.97K- 25.98% |
$2.79K - $5.9K
|
8.46K
$14.5K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-4.26K- 47.0% |
$4K - $8.47K
|
4.8K
$8.26K
|
|
|
Nov 14, 2024
Q3 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-6K- 81.07% |
$5.64K - $11.9K
|
1.4K
$2.41K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-65.4K- 55.13% |
$61.5K - $130K
|
53.3K
$91.6K
|